These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32367505)

  • 1. Changes in the Expression of SNAP-25 Protein in the Brain of Juvenile Rats in Two Models of Autism.
    Lenart J; Bratek E; Lazarewicz JW; Zieminska E
    J Mol Neurosci; 2020 Sep; 70(9):1313-1320. PubMed ID: 32367505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Select putative neurodevelopmental toxins modify SNAP-25 expression in primary cultures of rat cerebellar granule cells.
    Zieminska E; Lenart J; Lazarewicz JW
    Toxicology; 2016 Aug; 370():86-93. PubMed ID: 27693314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism.
    Miyazaki K; Narita N; Narita M
    Int J Dev Neurosci; 2005; 23(2-3):287-97. PubMed ID: 15749253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of reference genes for quantitative real-time PCR in valproic acid rat models of autism.
    Zhou J; Zhang X; Ren J; Wang P; Zhang J; Wei Z; Tian Y
    Mol Biol Rep; 2016 Aug; 43(8):837-47. PubMed ID: 27287459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between SNAP-25 gene polymorphisms and cognition in autism: functional consequences and potential therapeutic strategies.
    Braida D; Guerini FR; Ponzoni L; Corradini I; De Astis S; Pattini L; Bolognesi E; Benfante R; Fornasari D; Chiappedi M; Ghezzo A; Clerici M; Matteoli M; Sala M
    Transl Psychiatry; 2015 Jan; 5(1):e500. PubMed ID: 25629685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies.
    Toczylowska B; Zieminska E; Senator P; Lazarewicz JW
    Mol Neurobiol; 2020 Jul; 57(7):3089-3105. PubMed ID: 32468248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid.
    Servadio M; Manduca A; Melancia F; Leboffe L; Schiavi S; Campolongo P; Palmery M; Ascenzi P; di Masi A; Trezza V
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):85-96. PubMed ID: 29174949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the endocannabinoid system in the rat valproic acid model of autism.
    Kerr DM; Downey L; Conboy M; Finn DP; Roche M
    Behav Brain Res; 2013 Jul; 249():124-32. PubMed ID: 23643692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid.
    Gąssowska-Dobrowolska M; Kolasa-Wołosiuk A; Cieślik M; Dominiak A; Friedland K; Adamczyk A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Notch signaling pathway inhibitor Dapt alleviates autism-like behavior, autophagy and dendritic spine density abnormalities in a valproic acid-induced animal model of autism.
    Zhang Y; Xiang Z; Jia Y; He X; Wang L; Cui W
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109644. PubMed ID: 31075347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.
    Narita N; Kato M; Tazoe M; Miyazaki K; Narita M; Okado N
    Pediatr Res; 2002 Oct; 52(4):576-9. PubMed ID: 12357053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social behavior, neuroimmune markers and glutamic acid decarboxylase levels in a rat model of valproic acid-induced autism.
    Win-Shwe TT; Nway NC; Imai M; Lwin TT; Mar O; Watanabe H
    J Toxicol Sci; 2018; 43(11):631-643. PubMed ID: 30404997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal exposure to valproate induces sex-, age-, and tissue-dependent alterations of cholesterol metabolism: Potential implications on autism.
    Cartocci V; Tonini C; Di Pippo T; Vuono F; Schiavi S; Marino M; Trezza V; Pallottini V
    J Cell Physiol; 2019 Apr; 234(4):4362-4374. PubMed ID: 30341891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
    Matsuo K; Yabuki Y; Fukunaga K
    Neuropharmacology; 2020 May; 168():107975. PubMed ID: 31991146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism.
    Hirsch MM; Deckmann I; Santos-Terra J; Staevie GZ; Fontes-Dutra M; Carello-Collar G; Körbes-Rockenbach M; Brum Schwingel G; Bauer-Negrini G; Rabelo B; Gonçalves MCB; Corrêa-Velloso J; Naaldijk Y; Castillo ARG; Schneider T; Bambini-Junior V; Ulrich H; Gottfried C
    Neuropharmacology; 2020 May; 167():107930. PubMed ID: 31904357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of sphingosine 1-phosphate (S1P) attenuates spatial learning and memory impairments in the valproic acid rat model of autism.
    Wu H; Zhang Q; Gao J; Sun C; Wang J; Xia W; Cao Y; Hao Y; Wu L
    Psychopharmacology (Berl); 2018 Mar; 235(3):873-886. PubMed ID: 29218394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.
    Dufour-Rainfray D; Vourc'h P; Le Guisquet AM; Garreau L; Ternant D; Bodard S; Jaumain E; Gulhan Z; Belzung C; Andres CR; Chalon S; Guilloteau D
    Neurosci Lett; 2010 Feb; 470(1):55-9. PubMed ID: 20036713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat.
    Narita M; Oyabu A; Imura Y; Kamada N; Yokoyama T; Tano K; Uchida A; Narita N
    Neurosci Res; 2010 Jan; 66(1):2-6. PubMed ID: 19755133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism.
    Al-Askar M; Bhat RS; Selim M; Al-Ayadhi L; El-Ansary A
    BMC Complement Altern Med; 2017 May; 17(1):259. PubMed ID: 28486989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.